Qiuping Zhang
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
NSD2 mediates NF-κB and matrix metalloproteinases to drive hepatocellular carcinoma malignant progression.
Journal: Translational cancer research
Published: April 15, 2025
Matrin-3 acts as a potential biomarker and promotes hepatocellular carcinoma progression by interacting with cell cycle-regulating genes.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 22, 2024
Pathological components and CT imaging analysis of the area adjacent pleura within the pure ground-glass nodules with pleural deformation in invasive lung adenocarcinoma.
Journal: BMC cancer
Published: June 09, 2022
TTYH3, a potential prognosis biomarker associated with immune infiltration and immunotherapy response in lung cancer.
Journal: International immunopharmacology
Published: April 28, 2022
HO-1/CO Maintains Intestinal Barrier Integrity through NF-κB/MLCK Pathway in Intestinal HO-1-/- Mice.
Journal: Oxidative medicine and cellular longevity
Published: November 21, 2020
Contributions of HO-1-Dependent MAPK to Regulating Intestinal Barrier Disruption.
Journal: Biomolecules & therapeutics
Published: June 28, 2020
CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment.
Journal: Cancer cell international
Published: December 01, 2019
UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma.
Journal: Journal of cellular and molecular medicine
Published: November 04, 2019
Last Updated: 09/26/2026